首页
> 会议日程详情
2025-06-13
2025-06-14
16:00-16:10
【B座-4层-402】
EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC)